Fundamental analysis · SEC EDGAR · TTM through 31/03/2026

Fundamental analysis of Cigna Group

CI · NYSE · Hospital & Medical Service Plans

Fundamental quality

DEMANDING

54

out of 100

Breakdown by area

I.GrowthEPS: 3% · Revenue: 14.2%
56
II.ProfitabilityNet margin: 2.3% · ROE: 14.9%
53
III.Financial healthNet debt/EBITDA: 2.76x · FCF: 2.8%
52

Source: SEC EDGAR · TTM through 31/03/2026

Reading the numbers

On average over recent years, earnings per share grew 3% a year and revenue advanced 14.2% a year.

On profitability, Cigna Group shows a net margin of 2.3%, an ROE of 14.9%.

Its financial health shows net debt of 2.76 times its EBITDA and a free cash flow margin of 2.8%.

Adding up growth, profitability and financial strength, the traffic light gives CI a fundamental quality of 54 out of 100. To also know whether it's cheap or expensive, the price is missing: enter it in the tool and you'll get the valuation verdict (P/E against its sector).

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Cigna Group cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Cigna Group?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →